Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Maladaptive cognition-behavior patterns" is **not a molecular target** such as a receptor, enzyme, transporter, or gene. Instead, it refers to **patterns of thinking and acting that are ineffective or counterproductive in meeting one's needs or goals**. These behaviors and thought processes provide short-term relief from stressors but ultimately contribute to long-term emotional and psychological difficulties. Examples include avoidance behaviors, self-harm, substance abuse, compulsive actions like hair-pulling or skin-picking, emotional outbursts such as uncontrolled anger or crying episodes. Maladaptive cognitive patterns often involve negative and irrational thoughts—known as cognitive distortions—such as overgeneralization and black-and-white thinking. These can lead to unhealthy behavioral responses that interfere with daily functioning. Such patterns are commonly observed in various mental health disorders including anxiety disorders, depression, personality disorders, neurodevelopmental conditions like autism spectrum disorder, trauma-related conditions, eating disorders, and substance use disorders. While these maladaptive behaviors are important clinical concepts for diagnosis and treatment planning in psychology/psychiatry—and may be addressed through therapy techniques like behavior modification—they do not represent discrete biological entities that can serve as drug targets. Therefore: • This entry is **incorrect** if listed among molecular targets. • It should not be considered a canonical therapeutic target for pharmacological intervention. • No specific drugs "interact" with this entity directly; rather medications may address symptoms related to the underlying psychiatric condition. If you require structured information on an actual molecule/receptor involved in maladaptive behavior pathways—such as serotonin transporter (SERT), dopamine receptors D2/D3—or wish for details on specific neurotransmitter systems implicated in these behavioral/cognitive phenomena instead of the broad clinical concept itself, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Maladaptive cognition-behavior patterns.